- Research article
- Open Access
The SseC translocon component in Salmonella enterica serovar Typhimurium is chaperoned by SscA
BMC Microbiologyvolume 13, Article number: 221 (2013)
Salmonella enterica is a causative agent of foodborne gastroenteritis and the systemic disease known as typhoid fever. This bacterium uses two type three secretion systems (T3SSs) to translocate protein effectors into host cells to manipulate cellular function. Salmonella pathogenicity island (SPI)-2 encodes a T3SS required for intracellular survival of the pathogen. Genes in SPI-2 include apparatus components, secreted effectors and chaperones that bind to secreted cargo to coordinate their release from the bacterial cell. Although the effector repertoire secreted by the SPI-2 T3SS is large, only three virulence-associated chaperones have been characterized.
Here we report that SscA is the chaperone for the SseC translocon component. We show that SscA and SseC interact in bacterial cells and that deletion of sscA results in a loss of SseC secretion, which compromises intracellular replication and leads to a loss of competitive fitness in mice.
This work completes the characterization of the chaperone complement within SPI-2 and identifies SscA as the chaperone for the SseC translocon.
Bacterial pathogens exploit host niches using strategies that block or modify host defense pathways. One such strategy employed by the Gram-negative bacterium Salmonella enterica, is the translocation of effector proteins into the host cell through a type three secretion system (T3SS). S. enterica serovar Typhimurium (S. Typhimurium) has two T3SSs encoded within Salmonella pathogenicity island-1 (SPI-1) and SPI-2 that facilitate invasion and intracellular survival within host cells [1–3]. The assembly of the T3SS is complex, involving the formation of membrane channels in the bacterial inner and outer membrane, and a terminal translocon that forms a pore in host membranes.
Both SPI-1 and SPI-2 encode a distinct group of chaperones that bind to their cognate cargo proteins to coordinate T3SS assembly and secretion of effectors. Virulence chaperones belong to one of three defined classes : class I chaperones bind to single (IA) or multiple (IB) effectors, class II chaperones interact with translocon components, and class III chaperones partner with apparatus components. Among each of the different classes, chaperones share structural similarity yet their amino acid sequence can be poorly conserved. As such, many chaperones have been first identified based on low sequence identity with previously characterized proteins, and by shared physical properties such as isoelectric point (pI). Class I chaperones tend to be small proteins (~9-15 kDa) with acidic pI, and function as dimers adopting a horseshoe-like shape [5–7]. Class II chaperones also form dimers but do not have an acidic pI, which reflects a different interaction surface required for substrate binding [8, 9].
In addition to directing secretion events, chaperone-cargo pairs can function as regulatory proteins for T3SS gene expression . The FlgN chaperone interacts with FlgK-FlgL to form a repressive complex that inhibits expression of late flagellar genes . The Yersinia virulence plasmid encodes the chaperone SycD (also known as LcrH) that aids in the secretion of the translocon components YopB and YopD, the latter of which is responsible for establishing a negative feedback loop to prevent effector gene expression at early stages of infection . As SycD is required for YopD stability in the cytosol, both chaperone and cargo are necessary for proper coordination of Yop expression.
In S. enterica, over twenty effectors secreted by the SPI-2 T3SS have been identified yet the full complement of virulence chaperones involved in their secretion remains to be identified or functionally analyzed. To date, three virulence chaperones have been characterized; we showed that SrcA chaperones the effectors SseL and PipB2 and binds to the T3SS ATPase SsaN . The SscB chaperone directs the secretion of SseF , and the class II chaperone, SseA, is responsible for the secretion of the putative translocon platform protein SseB and one of the two translocon proteins, SseD, but not SseC [14–16]. Comparative sequence analysis of SPI-2 identified a putative chaperone gene called sscA but its function had yet to be demonstrated. In light of these findings, we set out to identify and characterize the chaperone involved in secretion of the SseC translocon protein, with an a priori focus on the sscA gene in SPI-2. In this study we demonstrate that SscA interacts with SseC and is required for its secretion but is dispensable for secretion of the other translocon components SseD and SseB. Both SscA and SseC were required for fitness in infected mice and in vitro macrophage infection assays.
Identification of SscA as a chaperone for SseC
SscA was previously predicted to be a chaperone based on comparisons to other T3SS-associated chaperones and therefore we prioritized it for analysis . SscA is an ~18 kDa protein that has 46% sequence identity to SycD, a translocon chaperone in Yersinia. Using the SycD crystal structure as a model (PDB-2VGY), the secondary structure prediction for SscA  showed a solely α-helical protein consisting of eight α-helices and a large tetratricopeptide repeat (TPR) domain from amino acids 36 to 137 (Figure 1). This helical structure is similar to that found in SycD  while the TPR domain has been shown in mutational studies and structural work to be involved in cargo binding for class II chaperones [19, 20]. Based on this structural comparison, we aimed to further characterize SscA as a potential class II chaperone in the SPI-2 T3SS.
SscA interacts with the translocon protein SseC
Chaperones exert their biological function in T3SS export through a physical interaction with cargo proteins. Because the class II chaperone SseA binds the translocon components SseB and SseD but not SseC, this suggested that another chaperone interacts with SseC. The structural similarity of SscA to SycD made this protein a logical candidate. To test this hypothesis we immunoprecipitated SscA-FLAG from bacterial cells and analyzed the co-precipitated proteins by Western blot with anti-SseC antiserum. SseC was pulled down only in the Salmonella strain expressing SscA-FLAG and not from control lysates generated from untagged wild type cells (Figure 2A). To verify this interaction, we performed a reciprocal co-IP by pulling down SseC-FLAG and showing co-precipitation of SscA-His6 in the eluted protein fraction (Figure 2B). To examine the specificity of the SscA-SseC interaction, we tested whether SscA-FLAG could immunoprecipitate other members of the translocon apparatus, including SseB and SseD, which it did not (Figure 2C). These data indicated that SscA interacted with SseC, but not the other translocon proteins.
SscA is necessary for secretion of SseC
To determine if the interaction between SscA and SseC was necessary for SseC secretion, we performed an in vitro secretion assay using wild type and ΔsscA under conditions that activate expression and activity of the SPI-2 T3SS. The secreted protein fraction from the culture supernatant of both wild type S. Typhimurium and ΔsscA was immunoblotted for the translocon proteins SseB, SseC, and SseD using specific antisera. The sscA mutant failed to secrete SseC as this protein was absent from the secreted protein fraction despite abundant levels in the bacterial cytoplasmic fraction (Figure 3A). SseC was detected in both the secreted protein and cytoplasmic fractions from wild type Salmonella and deletion of sscA had no demonstrable effect on the secretion of SseB or SseD (Figure 3A). To verify this phenotype, we complemented the ΔsscA mutant by transforming it with a plasmid to restore sscA expression. This lead to detectable levels of SseC in the secreted protein fraction, albeit to lower levels than wild type (Figure 3B), likely due to the increased copy number of SscA relative to its SseC cargo.
SseC and SscA are required for fitness during infection
Given that SscA was required for secretion of the SseC translocon component, we measured the impact on bacterial fitness following the deletion of sseC and sscA. Deletion of either sscA or sseC reduced the ability of bacteria to survive in RAW264.7 macrophages compared to wild type (Figure 4A). The number of intracellular bacteria between 2 h and 20 h after infection was decreased to 10% of wild type in the sseC mutant, and to 50% of wild type in the sscA mutant. To determine whether similar phenotypes could be observed in animal infections, mice were orally gavaged with a mixed inoculum containing equal proportions of wild type and mutant bacteria and the competitive fitness was determined 3 days after infection in the spleen, liver and cecum. The competitive indices for both sseC and sscA mutant strains was below 0.20 and were statistically significant (Figure 4B and 4C). The CI for the sscA mutant was 0.18 (95% CI 0.08-0.27; spleen), 0.19 (95% CI 0.31-0.35; liver), and 0.13 (95% CI -0.01-0.20; cecum). Values for the sseC mutant were 0.15 (95% CI 0.09-0.21; spleen), 0.09 (95% CI 0.04-0.13; liver), and 0.10 (95% CI -0.01-0.20; cecum). These results indicated that both SseC and SscA are critical for infection of macrophages and for competitive fitness in animals.
Protein-chaperone interactions are essential for T3SS function because they coordinate the delivery and secretion of substrate cargo. Class II virulence chaperones are particularly important since they direct translocon secretion as a prerequisite step for the proper delivery of all subsequent effectors into the host cell. Given the modest sequence similarity between the Yersinia class II virulence chaperone SycD and SscA, we analyzed SscA as the potential chaperone for the SseC translocon in the Salmonella SPI-2 T3SS. The structure of SycD shows a crescent shape molecule with the concave face possessing protein interaction sites that are common between SycD and SscA (i.e. Y40, Y52, Y93) . The Shigella class II chaperone IpgC possesses a similar structure with the concave face binding an amino acid region of its cognate cargo IpaD , suggesting that a common cargo-binding region may exist among class II virulence chaperones.
Using protein-protein interaction studies and secretion assays we demonstrated that SscA is the class II virulence chaperone for SseC and showed that this interaction is important for Salmonella pathogenicity as deletion of either sscA or sseC lead to similar attenuated phenotypes in mouse infections. As documented previously, effectors can be secreted to the cell surface of the bacteria in the absence of a functional translocon, however delivery of effector proteins into host cells requires an assembled translocon apparatus [23, 24]. Interestingly, the sseC mutant had a more pronounced negative effect on replication in RAW264.7 cells suggesting an additional role for SseC that does not depend on its secretion, or that a very small number of bacteria assemble a functional translocon in the absence of the SscA chaperone, allowing for some measure of phenotype recovery in vitro. This latter possibility was suggested for Yersinia LcrH point mutants that had reduced secretion of translocon proteins but retained some ability to intoxicate host cells from a minimal number of T3SS . In our system, we find this possibility unlikely because we found no evidence for SseC secretion in the absence of SscA chaperone even for highly concentrated samples, and the attenuation level of the sscA and sseC mutants was similar in animal infections.
All experiments with animals were conducted according to guidelines set by the Canadian Council on Animal Care. The local animal ethics committee, the Animal Review Ethics Board at McMaster University, approved all protocols developed for this work.
Bacterial strains, cloning, and growth conditions
Salmonella enterica serovar Typhimurium strain SL1344 (S. Typhimurium) was used as the wild type parent strain for all mutants generated in this study. Genomic mutations were made using the lambda red mutagenesis method . Electrocompetent cells containing the helper plasmid pKD46 were transformed with PCR-amplified linear DNA cassettes encoding the kanamycin resistance gene from the template plasmid pKD4 and flanked with 50 bp ends homologous for the targeted gene. Successful recombinants were recovered by antibiotic selection and screened by PCR for correct gene disruption. To generate FLAG-epitope fusion proteins for immunoprecipitation experiments, the full-length sscA gene was cloned into the plasmid pFLAG-CTC (Sigma) as a HindIII/SalI fragment and full-length sseC was cloned as an NdeI/SalI fragment using the primers listed in Table 1. Expression was induced from P tac using IPTG. To generate an sscA fusion to the hexa-histidine (His6) epitope, full-length sscA was amplified from chromosomal SL1344 DNA using primers that incorporated the His6 epitope (Table 1). This fragment was cloned first into pBAD24  as an NheI/HindIII fragment and then subcloned along with PBAD into pACYC (New England Biolabs) as a BamHI/HindIII fragment to generate an arabinose-inducible sscA-His 6 fusion. Strains, plasmids and primer sequences used in this work are provided in Table 1. The minimal medium LPM at pH 5.8 (5 mM KCl, 7.5 mM (NH4)2SO4, 0.5 mM K2SO4, 80 mM MES, 38 mM glycerol, 0.1% casamino acids, 8 μM MgCl2, 337 μM PO43-), was used to induce the expression of SsrB-regulated genes as described previously . Bacterial cultures were grown at 37°C with shaking at 225 rpm unless otherwise indicated.
Co-immunoprecipitations (co-IP) were performed with S. Typhimurium expressing SscA-FLAG or SseC-FLAG from the IPTG-inducible pFLAG-CTC plasmid. A strain carrying empty plasmid was used as a control. Strains were grown overnight in Luria-Bertani broth (LB) and sub-cultured 1:50 into 50 ml of LPM medium and grown to an optical density (OD600) of 0.6 at 37°C. Cultures were then centrifuged at 3000 × g for 10 min, and re-suspended in phosphate buffered saline (PBS) containing mini-EDTA protease inhibitor cocktail (PBS-PI; Roche). Cells were lysed by 6 pulses of sonication for 30 sec each, with 60 sec intervals between sonication (Misonix Sonicator 3000, Misonix). Lysates were centrifuged at 3000 × g for 15 min at 4°C and the supernatant removed to obtain the cytosolic protein fraction. M2-agarose beads conjugated with anti-FLAG antibodies (F-gel; Sigma) was equilibrated with PBS-PI containing 10 μg/ml bovine serum albumin (BSA) for 60 min at 4°C with rocking and washed with PBS-PI three times. The beads were mixed with the cytosolic protein fractions and incubated for 16 h at 4°C with end-on-end mixing. Unbound proteins were removed by centrifuging the F-gel at 1000 × g for 5 min and removing the supernatant. The F-gel was washed ten times with PBS-PI containing 0.1% Triton-X100 before eluting bound proteins into sodium dodecyl sulfate (SDS)-sample buffer (1M Tris pH 8.0, 20% SDS, 0.5 M EDTA pH 8, 10% glycerol, 200 mM dithiothreitol). Bound proteins were resolved by SDS-PAGE and transferred to polyvinylidene difluoride membranes (Bio-Rad). Western blots were probed with antibodies to SseC (a gift from Dr. Michael Hensel), the FLAG epitope (Sigma), or the His6 tag (Qiagen). For reciprocal co-immunoprecipitations, a strain containing a plasmid encoding sscA-HIS 6 and a second compatible plasmid encoding sseC-FLAG was used. SscA-His6 was induced with arabinose and SseC-FLAG was induced with IPTG as above. In this experiment, the anti-FLAG gel was used for immunoprecipitations and anti-His antibody used in immunoblotting as described above.
Protein secretion assasy
Wild type S. Typhimurium and ΔsscA strains were grown overnight in LB and sub-cultured 1:50 into LPM and grown to OD600 of 0.6. Cultures were then centrifuged for 2 min at 10,000 × g and the supernatant was filtered through a 0.2 μm filter (Pall Scientific) and precipitated with 10% trichloroacetic acid (TCA). Precipitated secreted proteins were centrifuged at 16,000 × g at 4°C for 30 min and the pellets were washed with acetone and dissolved in SDS-sample buffer. The whole cell lysate fraction was made by dissolving the bacterial pellet in SDS-sample buffer. To ensure equal protein loading in SDS-PAGE, the volume of SDS sample buffer was adjusted according to the optical density of the original culture. Protein samples were analyzed by Western blot using antibodies to DnaK (Convance), SseC (a gift from Dr. Michael Hensel), SseB, SseD, and SseG (a gift from Dr. John Brumell).
Macrophage replication assays
RAW264.7 cells were grown in Dulbecco’s Modified Eagle Medium (DMEM; Gibco) supplemented with 10% fetal bovine serum (FBS; Invitrogen) at 37°C with 5% CO2. Cells were seeded 16 h prior to infection into 24-well plates at a density of 2 × 105 cells per well. Overnight cultures of bacteria were washed with PBS, diluted in DMEM/10% FBS, and used to infect macrophages at a multiplicity of infection (MOI) of 50 for 30 min at 37°C, 5% CO2. Infected cells were washed three times with PBS and the media was replaced with DMEM/10% FBS/100 μg/mL gentamicin for 1.5 h to kill extracellular bacteria. Cells were then washed twice with PBS and incubated for 20 h in DMEM/10% FBS with10 μg/mL gentamicin. At 2 h and 20 h after infection, the cells were washed twice with PBS then lysed with 1% Triton X-100, 0.1% SDS in PBS to release intracellular bacteria. Colony forming units (cfu) were determined by plating serially-diluted lysates onto LB agar plates containing appropriate antibiotics. Experiments were performed twice independently using 3 technical replicates per assay.
Competitive infections were performed in female C57BL/6 mice (Charles River) by oral inoculation of a 0.1 ml mixture containing equal numbers (1×108 cfu) of a chloramphenicol resistant wild type strain (ushA::Cm) and mutant strains as described previously . The marked wild type strain was previously shown to be phenotypically neutral . Three days after infection, the spleen, liver and cecum was removed, homogenized in ice-cold PBS (Mixer Mill, Retsch) and serially diluted in PBS. The competitive index (CI) was determined by plating dilutions of the homogenized tissue lysates on agar plates containing streptomycin and incubating overnight at 37°C to recover both wild type and mutant bacteria. Colonies were then replica-stamped onto separate plates containing streptomycin and chloramphenicol to enumerate wild type and mutant bacteria. The CI was calculated as (cfu mutant/cfu wild type)output/(cfu mutant/cfu wild type)input. Mouse experiments were performed twice using groups of 5 mice for each experiment. Statistical analysis was performed using a Student t test.
In summary, we have verified that SscA is the chaperone for the SseC translocon component in the T3SS encoded by SPI-2. This work completes the characterization of the known chaperone complement within SPI-2. In future work, it will be useful to investigate whether this particular chaperone-cargo pair has any additional regulatory function on gene expression within SPI-2.
Conducted experiments and analyzed data: CAC, DTM, SEA. Wrote manuscript: CAC, DTM, BKC. Edited manuscript and provided essential discussion: CAC, DTM, SEA, AVCP, BKC. All authors read and approved the final manuscript.
Salmonella pathogenicity Island
Type 3 secretion system
- S. Typhimurium:
Salmonella enterica serovar Typhimurium
Groisman EA, Ochman H: Cognate gene clusters govern invasion of host epithelial cells by Salmonella typhimurium and Shigella flexneri. EMBO J. 1993, 12 (10): 3779-3787.
Shea JE, Hensel M, Gleeson C, Holden DW: Identification of a virulence locus encoding a second type III secretion system in Salmonella typhimurium. Proc Natl Acad Sci USA. 1996, 93 (6): 2593-2597. 10.1073/pnas.93.6.2593.
Ochman H, Soncini FC, Solomon F, Groisman EA: Identification of a pathogenicity island required for Salmonella survival in host cells. Proc Natl Acad Sci USA. 1996, 93 (15): 7800-7804. 10.1073/pnas.93.15.7800.
Cornelis GR: The type III secretion injectisome. Nat Rev Microbiol. 2006, 4 (11): 811-825. 10.1038/nrmicro1526.
Cooper CA, Zhang K, Andres SN, Fang Y, Kaniuk NA, Hannemann M, Brumell JH, Foster LJ, Junop MS, Coombes BK: Structural and biochemical characterization of SrcA, a multi-cargo type III secretion chaperone in Salmonella required for pathogenic association with a host. PLoS pathogens. 2010, 6 (2): e1000751-10.1371/journal.ppat.1000751.
Luo Y, Bertero MG, Frey EA, Pfuetzner RA, Wenk MR, Creagh L, Marcus SL, Lim D, Sicheri F, Kay C, et al: Structural and biochemical characterization of the type III secretion chaperones CesT and SigE. Nat Struct Biol. 2001, 8 (12): 1031-1036. 10.1038/nsb717.
Stebbins CE, Galan JE: Maintenance of an unfolded polypeptide by a cognate chaperone in bacterial type III secretion. Nature. 2001, 414 (6859): 77-81. 10.1038/35102073.
Buttner CR, Sorg I, Cornelis GR, Heinz DW, Niemann HH: Structure of the Yersinia enterocolitica type III secretion translocator chaperone SycD. J Mol Biol. 2008, 375 (4): 997-1012. 10.1016/j.jmb.2007.11.009.
Yip CK, Finlay BB, Strynadka NC: Structural characterization of a type III secretion system filament protein in complex with its chaperone. Nat Struct Mol Biol. 2005, 12 (1): 75-81. 10.1038/nsmb879.
Parsot C, Hamiaux C, Page AL: The various and varying roles of specific chaperones in type III secretion systems. Curr Opin Microbiol. 2003, 6 (1): 7-14. 10.1016/S1369-5274(02)00002-4.
Bennett JC, Thomas J, Fraser GM, Hughes C: Substrate complexes and domain organization of the Salmonella flagellar export chaperones FlgN and FliT. Mol Microbiol. 2001, 39 (3): 781-791. 10.1046/j.1365-2958.2001.02268.x.
Francis MS, Lloyd SA, Wolf-Watz H: The type III secretion chaperone LcrH co-operates with YopD to establish a negative, regulatory loop for control of Yop synthesis in Yersinia pseudotuberculosis. Mol Microbiol. 2001, 42 (4): 1075-1093. 10.1046/j.1365-2958.2001.02702.x.
Dai S, Zhou D: Secretion and function of Salmonella SPI-2 effector SseF require its chaperone, SscB. J Bacteriol. 2004, 186 (15): 5078-5086. 10.1128/JB.186.15.5078-5086.2004.
Coombes BK, Brown NF, Kujat-Choy S, Vallance BA, Finlay BB: SseA is required for translocation of Salmonella pathogenicity island-2 effectors into host cells. Microbes Infect. 2003, 5 (7): 561-570. 10.1016/S1286-4579(03)00094-7.
Ruiz-Albert J, Mundy R, Yu XJ, Beuzon CR, Holden DW: SseA is a chaperone for the SseB and SseD translocon components of the Salmonella pathogenicity-island-2-encoded type III secretion system. Microbiology. 2003, 149 (Pt 5): 1103-1111.
Zurawski DV, Stein MA: SseA acts as the chaperone for the SseB component of the Salmonella Pathogenicity Island 2 translocon. Mol Microbiol. 2003, 47 (5): 1341-1351. 10.1046/j.1365-2958.2003.03373.x.
Hensel M, Shea JE, Waterman SR, Mundy R, Nikolaus T, Banks G, Vazquez-Torres A, Gleeson C, Fang FC, Holden DW: Genes encoding putative effector proteins of the type III secretion system of Salmonella pathogenicity island 2 are required for bacterial virulence and proliferation in macrophages. Mol Microbiol. 1998, 30 (1): 163-174. 10.1046/j.1365-2958.1998.01047.x.
Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997, 25 (17): 3389-3402. 10.1093/nar/25.17.3389.
Edqvist PJ, Broms JE, Betts HJ, Forsberg A, Pallen MJ, Francis MS: Tetratricopeptide repeats in the type III secretion chaperone, LcrH: their role in substrate binding and secretion. Mol Microbiol. 2006, 59 (1): 31-44. 10.1111/j.1365-2958.2005.04923.x.
Schreiner M, Niemann HH: Crystal structure of the Yersinia enterocolitica type III secretion chaperone SycD in complex with a peptide of the minor translocator YopD. BMC Struct Biol. 2012, 12: 13-10.1186/1472-6807-12-13.
Pollastri G, Przybylski D, Rost B, Baldi P: Improving the prediction of protein secondary structure in three and eight classes using recurrent neural networks and profiles. Proteins. 2002, 47 (2): 228-235. 10.1002/prot.10082.
Lunelli M, Lokareddy RK, Zychlinsky A, Kolbe M: IpaB-IpgC interaction defines binding motif for type III secretion translocator. Proc Natl Acad Sci USA. 2009, 106 (24): 9661-9666. 10.1073/pnas.0812900106.
Nikolaus T, Deiwick J, Rappl C, Freeman JA, Schroder W, Miller SI, Hensel M: SseBCD proteins are secreted by the type III secretion system of Salmonella pathogenicity island 2 and function as a translocon. J Bacteriol. 2001, 183 (20): 6036-6045. 10.1128/JB.183.20.6036-6045.2001.
Sory MP, Cornelis GR: Translocation of a hybrid YopE-adenylate cyclase from Yersinia enterocolitica into HeLa cells. Mol Microbiol. 1994, 14 (3): 583-594. 10.1111/j.1365-2958.1994.tb02191.x.
Edqvist PJ, Aili M, Liu J, Francis MS: Minimal YopB and YopD translocator secretion by Yersinia is sufficient for Yop-effector delivery into target cells. Microbes Infect. 2007, 9 (2): 224-233. 10.1016/j.micinf.2006.11.010.
Datsenko KA, Wanner BL: One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA. 2000, 97 (12): 6640-6645. 10.1073/pnas.120163297.
Guzman LM, Belin D, Carson MJ, Beckwith J: Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J Bacteriol. 1995, 177 (14): 4121-4130.
Coombes BK, Wickham ME, Brown NF, Lemire S, Bossi L, Hsiao WW, Brinkman FS, Finlay BB: Genetic and molecular analysis of GogB, a phage-encoded type III-secreted substrate in Salmonella enterica serovar typhimurium with autonomous expression from its associated phage. J Mol Biol. 2005, 348 (4): 817-830. 10.1016/j.jmb.2005.03.024.
Brown NF, Vallance BA, Coombes BK, Valdez Y, Coburn BA, Finlay BB: Salmonella pathogenicity island 2 is expressed prior to penetrating the intestine. PLoS pathogens. 2005, 1 (3): e32-10.1371/journal.ppat.0010032.
Coombes BK, Wickham ME, Lowden MJ, Brown NF, Finlay BB: Negative regulation of Salmonella pathogenicity island 2 is required for contextual control of virulence during typhoid. Proc Natl Acad Sci USA. 2005, 102 (48): 17460-17465. 10.1073/pnas.0505401102.
This work was supported by the Canadian Institutes of Health Research (CIHR; MOP-82704), the Natural Sciences and Engineering Research Council (NSERC) and the Canada Research Chairs program. CAC is the recipient of an NSERC postgraduate scholarship; DTM and SEA are each supported by a Canada Graduate Scholarship from the CIHR. BKC is the Canada Research Chair in Infectious Disease Pathogenesis.
The authors indicate that there are no competing interests.